Dr Anida Mesinovic

Senior Scientist, Translational Biology

Anida Mesinovic is a translational cardiovascular pharmacologist with experience in drug discovery across metabolic and cardiovascular disease.

At the Monash Institute of Pharmaceutical Sciences, Anida worked as a Postdoctoral Research Fellow, leading in vitro and in vivo pharmacology in drug discovery programs. She identified key evidence gaps, designed and executed targeted experiments that strengthened commercial potential, coordinated multi-disciplinary teams and collaborated with CROs and industry partners to deliver studies aligned with program priorities.

She developed complementary in vivo, ex vivo and human cell systems to model disease for therapeutic testing, including animal models of cardiometabolic disease, isolated heart and blood vessel platforms, and human iPSC-derived vascular and cardiac cells. She established assays across these systems to support target validation, mechanism of action and pharmacodynamic biomarker assessment, which enabled findings to be confirmed across models and helped de-risk targets and therapies.

Anida completed her PhD in the Drug Discovery Theme at the Monash Institute of Pharmaceutical Sciences. Her PhD investigated nitroxyl donors as a potential therapy for heart failure in type 2 diabetes, using animal models and human vascular cells.